D-1038-2017 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-1038-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Jul 11, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220. The recall status is terminated (terminated Apr 1, 2019). Affected quantity: 544 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
Jul 11, 2017
Termination Date
Apr 1, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
544 bottles

Product description

Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC 55111-229-90) and b) 500-count bottles (NDC 55111-229-05), Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA; Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA.

Reason for recall

Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.

Distribution pattern

Nationwide in the USA

Code information

Lot #: a) C700220, Exp 06/18; b) C700220, Exp 06/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1038-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1038-2017. Report a data issue: hello@regdatalab.com.